Scope Fluidics Spolka Akcyjna (FRA:S84) Pretax Margin %: -50,600.00% (As of Mar. 2026)


FRA:S84 Scope Fluidics Spolka Akcyjna FRA:S84
45 GF Score
Price €23.50
GF Value €26.71
! 4 Warning Signs
View Full Analysis

What is Scope Fluidics Spolka Akcyjna Pretax Margin %?

Scope Fluidics Spolka Akcyjna FRA:S84 -2.08% 45 Pretax Margin % is -50,600.00% as of Mar. 2026. GuruFocus rates FRA:S84 with a GF Score™ of 45/100 and a GF Value™ of €26.71. The stock has 4 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Scope Fluidics Spolka Akcyjna ranks worse than 99.01% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Scope Fluidics Spolka Akcyjna's Pre-Tax Income for the three months ended in Mar. 2026 was €-3.04 Mil. Scope Fluidics Spolka Akcyjna's Revenue for the three months ended in Mar. 2026 was €0.01 Mil. Therefore, Scope Fluidics Spolka Akcyjna's pretax margin for the quarter that ended in Mar. 2026 was -50,600.00%.

The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's Pretax Margin % or its related term are showing as below:

FRA:S84' s Pretax Margin % Range Over the Past 10 Years
Min: -208650   Med: -2769.5   Max: 97800.25
Current: -46639.42


FRA:S84's Pretax Margin % is ranked worse than
99.01% of 202 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.565 vs FRA:S84: -46639.42

Scope Fluidics Spolka Akcyjna  (FRA:S84) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Scope Fluidics Spolka Akcyjna Pretax Margin % Related Terms


Scope Fluidics Spolka Akcyjna Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Scope Fluidics Spolka Akcyjna's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scope Fluidics Spolka Akcyjna Pretax Margin % Chart

Scope Fluidics Spolka Akcyjna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 97,479.35 -3,618.80 64,610.00 -45,447.83

Scope Fluidics Spolka Akcyjna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49,600.00 -1,300.68 -51,220.00 2,563.97 -50,600.00

FRA:S84 vs TMO, DHR, IDXX: Pretax Margin % Comparison

For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scope Fluidics Spolka Akcyjna Pretax Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Scope Fluidics Spolka Akcyjna's Pretax Margin % falls into.


FRA:S84
45GF Score
Scope Fluidics Spolka Akcyjna FRA:S84
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scope Fluidics Spolka Akcyjna Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Scope Fluidics Spolka Akcyjna's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.453/0.023
=-45,447.83 %

Scope Fluidics Spolka Akcyjna's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.036/0.006
=-50,600.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of -50,600.00% mean?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a Pretax Margin % of -50,600.00% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #200 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 99%.
Is Scope Fluidics Spolka Akcyjna's Pretax Margin % too high?
Scope Fluidics Spolka Akcyjna's current Pretax Margin % is -50,600.00%. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #200 out of 202 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's Pretax Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #200 out of 202 companies for Pretax Margin %. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Diagnostics & Research company?
A good Pretax Margin % depends on the Medical Diagnostics & Research industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. Scope Fluidics Spolka Akcyjna's current Pretax Margin % is -50,600.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current Pretax Margin % of -50,600.00%. The stock's GF Value™ is €26.71, compared to a current price of €23.50 — trading 12% below its estimated fair value. The current Pretax Margin % is -50,600.00%. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 45/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current Pretax Margin % is -50,600.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?

Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued. The current stock price of €23.50 is trading 12% below its estimated GF Value™ of €26.71.

Key valuation signals for FRA:S84:

  • Pretax Margin %: -50,600.00%
  • GF Value™: €26.71 vs. price of €23.50 (12% below fair value)
  • GF Score™: 45/100 with 4 warning signs

No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Scope Fluidics Spolka Akcyjna Business Description

Other Exchanges SCP:Poland
Address Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
45GF Score

Get the complete analysis for FRA:S84

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.50
Price
€26.71
GF Value